simvastatin has been researched along with Disease, Pulmonary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ong, HX; Pisano, E; Scalia, S; Traini, D; Tulbah, AS; Young, PM | 1 |
| Da Costa, AM; de Medina, G; Dewachter, C; Dewachter, L; Hupkens, E; Makanga, M; Maruyama, H; Naeije, R | 1 |
| Colombo, P; Ong, HX; Traini, D; Tulbah, AS; Young, PM | 1 |
| Farivar, AS; Fraga, C; Mulligan, MS; Naidu, BV; Thomas, R; Woolley, SM | 1 |
| Barnard, JW; Garcia, JG; Grigoryev, DN; Jacobson, JR; Ma, SF; Tuder, RM | 1 |
| Erkkilä, L; Haasio, K; Jauhiainen, M; Laitinen, K; Leinonen, M; Saikku, P; Tiirola, T | 1 |
| Hill, C; Kirkham, B; Zeitz, C | 1 |
1 review(s) available for simvastatin and Disease, Pulmonary
| Article | Year |
|---|---|
Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lung; Lung Diseases; Simvastatin | 2016 |
6 other study(ies) available for simvastatin and Disease, Pulmonary
| Article | Year |
|---|---|
Inhaled simvastatin nanoparticles for inflammatory lung disease.
Topics: Administration, Inhalation; Anti-Inflammatory Agents; Biological Transport; Chemistry, Pharmaceutical; Chronic Disease; Drug Carriers; Drug Liberation; Epithelial Cells; Humans; Inflammation; Lactic Acid; Lung Diseases; Mucus; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Simvastatin; Surface Properties | 2017 |
Prevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen-induced congenital diaphragmatic hernia.
Topics: Animals; Apoptosis; Bone Morphogenetic Protein Receptors, Type II; Female; Hernias, Diaphragmatic, Congenital; Lung; Lung Diseases; Phenyl Ethers; Pregnancy; Rats, Sprague-Dawley; Simvastatin; Vascular Remodeling | 2015 |
Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion.
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cell Count; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Ischemia; Lung; Lung Diseases; Male; Models, Cardiovascular; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Long-Evans; Reperfusion Injury; Simvastatin; Statistics as Topic; Time Factors; Transcription Factors; Treatment Outcome | 2003 |
Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury.
Topics: Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Capillary Permeability; Endothelial Cells; Endotoxins; Gene Expression Profiling; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipopolysaccharides; Lung; Lung Diseases; Lung Injury; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Simvastatin | 2005 |
Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice.
Topics: Animals; Chlamydia Infections; Chlamydophila pneumoniae; Dietary Fats; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lung Diseases; Mice; Simvastatin | 2005 |
Dermatomyositis with lung involvement in a patient treated with simvastatin.
Topics: Aged; Anticholesteremic Agents; Biopsy; Dermatomyositis; Fatal Outcome; Female; Humans; Hypercholesterolemia; Lovastatin; Lung Diseases; Muscle, Skeletal; Simvastatin | 1995 |